Review article

https://doi.org/10.2478/acph-2014-0036

Therapeutic drug monitoring of atypical antipsychotic drugs

MILAN GRUNDMANN ; Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava Czech Republic
IVANA KACIROVA ; Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava Czech Republic
ROMANA URINOVSKA ; Department of Clinical Pharmacology, Department of Laboratory Diagnostics, University Hospital Ostrava, Ostrava Czech Republic

Abstract

Filename: x14.pdf Grundman
Category: Review
Free Access?: N
Author(s):
DOI: 10.2478/acph-2014-0036
Include degrees?
Degree(s):
Affiliation(s):
Abstract: Schizophrenia is a severe psychiatric disorder often associated with cognitive impairment and affective, mainly depressive, symptoms. Antipsychotic medication is the primary intervention for stabilization of acute psychotic episodes and prevention of recurrences and relapses in patients with schizophrenia. Typical antipsychotics, the older class of antipsychotic agents, are currently used much less frequently than newer atypical antipsychotics. Therapeutic drug monitoring (TDM) of antipsychotic drugs is the specific method of clinical pharmacology, which involves measurement of drug serum concentrations followed by interpretation and good cooperation with the clinician. TDM is a powerful tool that allows tailor-made treatment for the specific needs of individual patients. It can help in monitoring adherence, dose adjustment, minimizing the risk of toxicity and in cost-effectiveness in the treatment of psychiatric disorders. The review provides complex knowledge indispensable to clinical pharmacologists, pharmacists and clinicians for interpretation of TDM results.

Keywords

therapeutic drug monitoring; antipsychotic drugs; therapeutic reference ranges

Hrčak ID:

123214

URI

https://hrcak.srce.hr/123214

Publication date:

31.12.2014.

Visits: 8.133 *